← FDA DRUG APPROVALS

FDA ANDA · ANDA086348

PROCHLORPERAZINE EDISYLATE

Sponsor: WYETH AYERST

APPLICATION
ANDA086348
TYPE
ANDA
ORIGINAL APPROVAL
1979-07-05
LATEST ACTION
1989-04-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROCHLORPERAZINE EDISYLATEDiscontinued
PROCHLORPERAZINE EDISYLATE EQ 5MG BASE/ML · INJECTABLE · INJECTION

Approval history

1989-04-27Labeling · Supplement 9AP
1987-05-01Manufacturing (CMC) · Supplement 2AP
1986-08-27Manufacturing (CMC) · Supplement 7AP
1984-11-29Manufacturing (CMC) · Supplement 5AP
1979-07-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →